Fluocortolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H29FO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65VXC1MH0J, chemically known as 6-alpha-fluoro-16-alpha-methylpregna-1,4-diene-11-beta,21-diol-3,20-dione but generally known as fluocortolone, which bears US NIH Compound Identifier 9053. European Medicines Agency schedules Fluocortolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07717MIG. The term FLUOCORTOLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules fluocortolone in its Anatomical Therapeutic Chemical (ATC) Classification. FLUOCORTOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluocortolone under HS 29372200 and SITC 54153. As of Q4 2014, FLUOCORTOLONE remains the US FDA Preferred Term for this commodity. Fluocortolone bears US NLM identifiers UMLS ID C0016301 and NCI Concept Code C80819. SMILES: FC1CC2C3C(C(C(C3)C)C(=O)CO)(CC(O)C2C2(C1=CC(=O)C=C2)C)C.